NextCure Inc (NXTC)

NextCure (NXTC) Stock Price & Analysis


NXTC Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.16 - $5.27
Previous Close$1.72
Average Volume (3M)65.54K
Market Cap
Enterprise Value$139.87M
Total Cash (Recent Filing)$29.97M
Total Debt (Recent Filing)$121.97M
Price to Earnings (P/E)-0.7
Aug 03, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.53
Shares Outstanding27,834,911
10 Day Avg. Volume59,015
30 Day Avg. Volume65,539
Standard Deviation0.24
Financial Highlights & Ratios
Price to Book (P/B)0.33
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-2.08
Price Target Upside242.86% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was NextCure Inc’s price range in the past 12 months?
NextCure Inc lowest stock price was $1.16 and its highest was $5.27 in the past 12 months.
    What is NextCure Inc’s market cap?
    Currently, no data Available
    When is NextCure Inc’s upcoming earnings report date?
    NextCure Inc’s upcoming earnings report date is Aug 03, 2023 which is in 64 days.
      How were NextCure Inc’s earnings last quarter?
      NextCure Inc released its earnings results on May 04, 2023. The company reported -$0.58 earnings per share for the quarter, beating the consensus estimate of -$0.62 by $0.04.
        Is NextCure Inc overvalued?
        According to Wall Street analysts NextCure Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does NextCure Inc pay dividends?
          NextCure Inc does not currently pay dividends.
          What is NextCure Inc’s EPS estimate?
          NextCure Inc’s EPS estimate is -$0.55.
            How many shares outstanding does NextCure Inc have?
            NextCure Inc has 27,834,911 shares outstanding.
              What happened to NextCure Inc’s price movement after its last earnings report?
              NextCure Inc reported an EPS of -$0.58 in its last earnings report, beating expectations of -$0.62. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of NextCure Inc?
                Among the largest hedge funds holding NextCure Inc’s share is Harbourvest Partners Llc. It holds NextCure Inc’s shares valued at 15K.


                  NextCure Stock Smart Score

                  The NextCure stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  NextCure Inc

                  NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lieping Chen in September 2015 and is headquartered in Beltsville, MD.


                  Top 5 ETFs holding NXTC

                  Market Value
                  Smart Score
                  iShares Core S&P Total U.S. Stock Market ETF
                  Up to five ETFs with an Outperform Smart Score that hold NXTC. The ETFs are listed according to market value of NXTC within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  MAIA Biotechnology, Inc.
                  Aligos Therapeutics
                  Sera Prognostics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis